Grigoris Gerotziafas: The Evolving Landscape of Genetic Risk Assessment in VTE
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Polish Archives of Internal Medicine, adding:
”The VAS Group is pleased to announce the publication of our latest review article in the Polish Archives of Internal Medicine (PAIM):
‘Inherited thrombophilia and polygenic risk scores in venous thromboembolism: from classical testing to genomic risk prediction’
This is an updated overview of the evolving landscape of genetic risk assessment in venous thromboembolism (VTE), moving from conventional inherited thrombophilia testing toward next-generation genomic and polygenic risk prediction approaches.
Key messages of the review include:
- The complex interaction between genetic, acquired, and environmental determinants of VTE
- The current and future role of classical thrombophilia testing (Factor V Leiden, Prothrombin G20210A, antithrombin, protein C and protein S deficiencies)
- The emergence of genome-wide association studies (GWAS)-derived polygenic risk scores as innovative tools for individualized VTE risk stratification
- The potential integration of genomic medicine into precision thrombosis prevention and management
- The major scientific and clinical barriers that still limit implementation in routine clinical practice
This publication highlights the growing importance of precision medicine and translational vascular science in the management of thrombotic disease.
Congratulations and sincere thanks to all co-authors and collaborators for this excellent international collaborative work.”
Title: Inherited thrombophilia and polygenic risk scores in venous thromboembolism: from classical testing to genomic risk prediction
Authors: Benilde Cosmi, Grigoris Gerotziafas, Peter Marschang, Matija Kozak, Mariella Catalano, Agata Stanek

Stay updated on all scientific advances with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers